PensionDanmark Pensionsforsikringsaktieselskab Increases Stake in Agilent Technologies, Inc. $A

Key Points

• PensionDanmark increased its Agilent Technologies stake by 9.6% during the second quarter, adding 7,371 shares to hold 83,766 shares valued at approximately $11.1 million.
• Analysts maintain a broadly positive outlook, with Agilent receiving a “Moderate Buy” consensus rating and an average price target of $159.35; TD Cowen raised its target to $155.
• Agilent exceeded quarterly expectations, reporting $1.49 in EPS and $1.83 billion in revenue, with year-over-year revenue growth of 10%. The company also pays a quarterly dividend of $0.255 per share, equal to a 0.7% annual yield.

PensionDanmark Pensionsforsikringsaktieselskab lifted its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 9.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,766 shares of the medical research company's stock after acquiring an additional 7,371 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab's holdings in Agilent Technologies were worth $11,127,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in A. Fiduciary Trust Co lifted its stake in shares of Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company's stock valued at $633,000 after purchasing an additional 77 shares during the last quarter. Freestone Capital Holdings LLC increased its position in shares of Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company's stock worth $574,000 after purchasing an additional 84 shares during the last quarter. Sapient Capital LLC raised its holdings in Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company's stock valued at $240,000 after buying an additional 85 shares during the period. Plan A Wealth LLC lifted its position in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company's stock valued at $403,000 after buying an additional 92 shares during the last quarter. Finally, IHT Wealth Management LLC lifted its position in Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company's stock valued at $278,000 after buying an additional 96 shares during the last quarter.

Analysts Set New Price Targets

A number of brokerages have weighed in on A. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, June 2nd. TD Cowen increased their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a "buy" rating in a research report on Thursday, May 28th. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 target price for the company. Finally, Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a "hold" rating and a $135.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $159.35.

Agilent Technologies Stock Performance

NYSE A opened at $146.04 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market cap of $41.25 billion, a P/E ratio of 29.32, a P/E/G ratio of 2.51 and a beta of 1.25. The stock has a 50-day moving average of $134.16 and a two-hundred day moving average of $125.18. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter in the prior year, the company earned $1.31 earnings per share. The business's quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies's dividend payout ratio is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source